Targeted death cancer cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 1, 2001
app pub date -
Apr 6, 2001
filing date -
Apr 6, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention relates to the use of an inducible genetic recombination system to target expression of a toxin to cancer cells and to hereby prevent the recurrence of particular tumors. The present invention also relates to the use of an inducible genetic recombination system to target expression of diphtheria toxin to androgen-independent cancer cells following androgen ablation therapy and to thereby prevent the development of recurrent prostatic tumors.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully